Synergistic Antibiotic Delivery Systems

The inventive concept integrates nanoparticles carrying antibiotics with distinct technologies such as AI, IoT, blockchain, and novel materials to create more powerful systems for targeted antibiotic delivery, adaptive resistance management, and personalized treatment planning.

The growing antibiotic resistance of harmful microbes has emerged as a significant concern in public health. Existing drug delivery methods and systems have limitations, including inadequate targeting and inefficient use of antibiotics. The original patent disclosed aqueous polyacrylate nanoparticle emulsions for water-solubilizing and encasing antibacterial compounds. However, it did not address the need for more advanced, synergistic systems that integrate multiple technologies to combat antibiotic resistance.

The inventive concept comprises four main components: 1) nanoparticles carrying antibiotics, 2) AI-powered algorithms for optimizing nanoparticle routes and detecting antibiotic resistance patterns, 3) blockchain-based platforms for secure data sharing and real-time adaptation of treatment strategies, and 4) integration with IoT-enabled systems and novel materials with enhanced antimicrobial properties. The system enables targeted antibiotic delivery, adaptive resistance management, and personalized treatment planning. The AI-powered algorithm analyzes genomic data to identify optimal antibiotic-nanoparticle combinations and integrates them into the blockchain-based platform for secure data sharing and personalized treatment planning.

The inventive concept's novelty lies in the synergistic integration of nanoparticles carrying antibiotics with AI, IoT, blockchain, and novel materials. The inventive step is the recognition that combining these distinct technologies can create a more powerful system for combating antibiotic resistance, which is not obvious from the original patent.

Alternative embodiments include using different types of nanoparticles, AI algorithms, or blockchain platforms. Variations may include integrating additional technologies, such as gene editing or synthetic biology, to further enhance the system's capabilities.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the development of targeted antibiotic delivery systems and personalized treatment planning. The market for antibiotic delivery systems is expected to grow significantly in the next decade, driven by the increasing need to combat antibiotic resistance.